The group will host six events across the globe, combining networking and education for practitioners of regenerative medicine
MIAMI LAKES, Florida— The International Society for Stem Cell Application (ISSCA), a worldwide leader in regenerative medicine education, has announced its slate of 2020 medical congresses. The group’s calendar includes dates at six locations across the globe 
Through its congresses, the ISSCA seeks to create a platform through which physicians can collaborate, share data, initiate discussions, and exchange information that may be directly translated to therapeutic applications. All doctors who want to share their medical research are welcome to attend, and the ISSCA welcomes abstract submissions and reviews them on a continuing basis. 
For the second year straight, the main topic discussed at ISSCA’s congresses will be how cellular products derived from birth tissue (allogeneic compounds) have revolutionized the industry by delivering safer, shorter stem cells procedures for practitioners. During each event, lecturers will respond to concerns attendees have about how regenerative medicine advances will satisfy FDA regulations and how new technologies could continue to help patients under new FDA laws.
This year, the ISSCA welcomes three new cities to its agenda—Salvador de Bahia, Brazil; Punta del Este, Uruguay; and Jakarta, Indonesia. The six congresses are as follows: 

• May 2020: Mexico City, Mexico
• June 2020: Caracas, Venezuela
• August 2020: Salvador de Bahia, Brazil
• October 2020: Buenos Aires, Argentina
• November 2020: Jakarta, Indonesia
• December 2020: Punta del Este, Uruguay

“We at the ISSCA are looking forward to this year’s calendar of congresses, which will provide invaluable networking and educational opportunities to physicians looking to expand their knowledge on current innovations and best practices concerning regenerative medicine,” noted Benito Novas, ISSCA VP of Public Relations. “Our global congresses expand on ISSCA’s mission to continue to serve as the premier educational resource for physicians across the globe looking to introduce stem cells treatments into their practices.”
To learn more about the ISSCA or to register for an upcoming congress, visit www.issca.us.

Adimarket Named as Distributor for Innovative GCell Micrograft Technology
The partnership between Adimarket and Global Medical Group delivers an FDA-compliant stem cells procedure to physicians practicing regenerative medicine across the globe
MIAMI LAKES, Florida—Adimarket, LLC, a subsidiary of the Global Stem Cells Group (GSCG), has entered an agreement with Global Medical Group (GMG) to distribute the brand’s newest product featuring GCell technology. It will be available for purchase to regenerative medicine practitioners via Adimarket’s online store. 
Global Medical Group recently announced the launch of their GCell micrograft technology, an autologous tissue suspension that boasts minimal manipulation. The product has application implications for a wide range of medical uses, including orthopedics, dermatology, cosmetic gynecology, aesthetics, and hair loss. 
GCell technology would allow regenerative medicine practitioners to continue practicing their adult stem cells-based procedures, as the product meets FDA compliance standards. GMG’s innovative product uses micrograft technology and is a closed system medical device that harnesses the natural and powerful restorative capabilities of adipose tissue. Because the procedure can be performed without using enzymes, GCell technology maintains FDA compliance. 
The GCell SVF (Stromal Vascular Fraction) procedure can be performed in-office in around 30 minutes, while previous procedures could take up to two hours. It also utilizes only local anesthesia, and performing physicians only have to collect 15 ml of fat instead of the 50 ml required for traditional protocols. 
GCell technology may hold exciting applications for clients looking for treatment options for wound care, hair loss, orthopedic conditions, or aesthetic concerns. 
“We are pleased to partner with the Global Medical Group to offer their cutting edge GCell technology in Adimarket’s product portfolio,” said Benito Novas, CEO of the Global Stem Cells Group. “There is a possibility that this innovative technology could lead to incredible advances in various treatment protocols, including those related to wound care, hair loss, orthopedic injuries, or aesthetics. And because it is FDA compliant, GCell technology will be a highly attractive option to regenerative medicine practitioners in the US and abroad.”  
The first unit will be launched in the US market next month. Physicians looking to incorporate GCell technology into their practices will be able to find it at www.adimarket.net. 

With video lectures and additional tools from some of the most respected names in today’s stem cells field, the course arms practitioners with the necessary knowledge and resources to offer innovative regenerative medicine treatments in their existing practices
MIAMI LAKES, Florida— The International Society for Stem Cell Application (ISSCA) (www.issca.us) has announced it has launched a new online stem cells course, Cellular Therapy. The course adds to the group’s already existing robust offering of onsite and online courses designed to give physicians looking to incorporate regenerative medicine protocols into their practices the education and tools necessary to do so.
Regenerative medicine has been increasingly gaining attention in today’s fast-paced medical world. As more researchers and physicians become interested in studying the field and introducing treatment protocols into their practices, it can be difficult to know which products and practices yield the best results for patients seeking these treatments for relief from degenerative diseases, noted Benito Novas, ISSCA VP of Public Relations. Knowing which products work for which conditions and how to safely administer them to maximize results are key in leading a successful regenerative medicine practice.
With the Cellular Therapy course and others offered by the ISSCA, physicians will learn these valuable protocols and more about product offerings and how to choose the most effective ones. The Cellular Therapy course will prepare physicians with the necessary theoretical and practical knowledge needed to effectively and safely secure better patient outcomes when using cellular therapies. With this training, physicians will gain knowledge from leading scientists in the field, learn valuable information on safety standards and quality control from top manufacturers, be positioned to perform these procedures and open a Stem Cell Center practice, join the ISSCA’s network, and enjoy the benefits of an exponentially growing industry worldwide.
Practitioners enrolling in the online course will gain access to online lectures from some of the leading names in the field of regenerative medicine spanning a number of topics critical to understanding the foundations of cellular therapy. In addition to online lectures, enrollees gain access to important supporting documents; The Condition Book, outlining stem cells treatment protocols for seven common conditions; and valuable case studies, all designed to deliver the knowledge needed to successfully implement stem cells treatments in a clinical setting.
And physicians looking to enroll in this course and other offerings by the ISSCA are in good hands. The group is widely considered as the global standard bearer when it comes to education and research in the regenerative medicine field. For years, the ISSCA has played a critical role in bridging the gap between the science behind stem cells and regenerative medicine and the practical application of that science in a clinical setting.
“We are pleased to add the online Cellular Therapy course to our growing number of course offerings designed to deliver the skills and education needed to practitioners eager to implement stem cells treatment protocols into their existing practices,” said Novas. “The course gives physicians the skills needed to utilize these highly effective treatments to help patients suffering from degenerative diseases while expanding on the ISSCA’s mission to continue to serve as the premier educational resource for physicians across the globe looking to introduce stem cells treatments into their practices.”
To learn more about the ISSCA, visit www.issca.us. To learn more about the group’s new online Cellular Therapy course or to register, visit https://www.cellulartherapycourse.com/

The organization seeks to improve education and access to stem cells therapies for physicians and patients worldwideThe organization seeks to improve education and access to stem cells therapies for physicians and patients worldwide
MIAMI LAKES, Florida—Following two recent highly successful conferences, the International Society for Stem Cell Application (ISSCA) is set to offer six additional events on its training calendar to round out 2019. Recent events attracting physicians across the globe include a conference held at the University of Miami and the ISSCA’s 6th Annual Regenerative Medicine Symposium in Buenos Aires. With its upcoming slate of events, the group is hoping to receive the same positive response.
One of the ISSCA’s missions is to share the latest in stem cells protocols and clinical applications with physicians across the globe, so they can implement stem cells therapies into their practices. By adding these protocols to their practices, physicians can help alleviate suffering and improve recuperation times for patients diagnosed with a host of degenerative diseases and injuries.
To accomplish its mission, the ISSCA will host the following events in 2019:

• Uccle, Belgium – November 15-16
• Mexico City – November  22-23
• Cochabamba, Bolivia – November 22-23
• Miami, FL – November 29-30
• Buenos Aires, Argentina – December 6-7
• Bogota, Colombia  – December 13-14

“We invite all physicians interested in adding stem cells therapies to their practices to join us at one of our upcoming conferences,” said Benito Novas, Vice President of Public Relations for ISSCA. “Attendees will learn from highly trained physicians and researchers in the field of regenerative medicine and take away the necessary education and tools to implement the latest stem cells therapies into their own practices.”
The ISSCA is a global leader in stem cells research, applications, and education, partnering with major global institutions and locations worldwide to host its independent medical congresses. To learn more about the ISSCA and its all of its past and upcoming events, visit http://www.issca.us

The regenerative medicine symposium was held on October 24-27 with nearly 200 attendees and over 20 expert speakers
MIAMI LAKES, Florida—The International Society for Stem Cell Application (ISSCA), in collaboration with SISDET, held a highly successful three-day medical conference on the University of Miami campus on October 24-26. The conference featured a host of international experts in regenerative medicine and introduced new standards in regenerative medicine protocols to those in attendance. The Miami conference is part of the ISSCA’s growing commitment to increasing the awareness and practice of regenerative medicine across the globe in an effort to help alleviate suffering for those diagnosed with degenerative diseases. 
Around 200 physicians, scientists, and researchers interested in regenerative medicine traveled to the University of Miami campus for the event. The conference focused on providing attendees with information on today’s most successful stem cells treatment protocols and the latest advances in regenerative medicine. Attendees heard from more than 20 expert speakers within the stem cells field, with lecturers from Europe, the US, and Latin America on the conference agenda. 
“This three-day event included recognized keynote speakers, as well as aspiring young physicians discussing the latest advances in stem cell biology in an informal and collaborative setting,” said Benito Novas, Vice President of Public Relations for ISSCA. “Our goal with all of our events is to strengthen the cooperative and dynamic spirit in this research area. We would also like to thank the University of Miami for hosting this event, as it was a great honor partnering with such a prestigious university.”  
ISSCA is a global leader in stem cells research, applications, and education, partnering with major global institutions and locations worldwide to host its independent medical congresses. To learn more about the ISSCA and its all of its past and upcoming events, visit http://www.issca.us

The courses will target physicians based in the Americas, providing them with critical stem cells education and tools needed to implement protocols in their own practices
The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, is hosting two upcoming courses in Miami. The courses will inform physicians on a range of topics about the latest stem cells protocols and how they can be incorporated into physicians’ own practices.
In continuing its commitment to help alleviate human suffering through expanding physician access to today’s cutting-edge stem cells technologies, the ISSCA is bringing its globally renowned courses to Miami, offering physicians two opportunities to participate. The course offered on November 1-2 is sold out, but seats still remain for the November 29-30 session for physicians looking to incorporate stem cells treatment protocols into their practices.
Doctors attending the Miami courses will learn about the latest trends and breakthroughs in in-office stem cells protocols. The ISSCA has also added a new topic into the Miami sessions: previously, the course covered autologous cell therapy, but in this newest course iteration, speakers will discuss how to add heterologous cell therapy into medical practices. In this training, physicians will learn about treatment protocols utilizing stem cells derived from neonatal tissue, such as cord blood, exosomes, and amniotic liquid. Attendees will learn both how these products are obtained as well as their most common clinical applications.
For those interested in learning more about the ISSCA’s upcoming courses in Miami or to register, visit https://www.stemcelltraining.net/hands-on-course/
“The ISSCA is pleased to bring our highly lauded courses on stem cells protocols to physicians in the Miami area and beyond,” said Benito Novas, ISSCA VP of Public Relations. “Our goal is to help physicians better treat their patients suffering from degenerative diseases by giving them the tools and education they need to implement these highly effective protocols in their own practices. Like all of our educational sessions, our Miami courses have been met with a great response, proving the growing interest in and efficacy of stem cells treatments.”
To learn more about all of the ISSCA’s latest news and innovations, visit  http://www.stemcellsgroup.com/

The ISSCA sponsored symposium is in its sixth year, sharing recent advancements in stem cells therapies with physicians looking to implement them into their own practices
The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, recently hosted a symposium in Buenos Aires, aimed at physicians looking to incorporate regenerative medicine into their practices.
The 6^th Simposio Mundial sobre Medicina Regenerativa y Terapias Celulares was held in Buenos Aires, Argentina on October 12-13, with 300 physicians in attendance. The event has become a premier global event in the world of regenerative medicine, attracting a growing number of returning physicians each year.
The 6^th annual event featured 13 expert speakers from five countries, including Argentina, Chile, Colombia, Bolivia, Cuba, and the US. The panel of speakers included practitioners within the regenerative medicine field as well as scientists currently working on developing new stem cells protocols and allogeneic compounds. Throughout the weekend, physicians attended lectures providing information on how stem cell therapies can help patients suffering from degenerative diseases.
The event was sponsored by the City of Buenos Aires, which was pleased to host the event in the city and has invited the group back next year to host its 7^th annual event.
All of the symposium’s lectures will be posted to ISSCA’s YouTube channel, with free viewing access to the public. Those interested in viewing the symposium’s lectures can visit
https://www.youtube.com/user/StemCellsGroup/videos.
“For six years now, ISSCA has proudly sponsored the Simposio Mundial sobre Medicina Regenerativa y Terapias Celulares, bringing physicians from across the globe together to learn about the newest advancements in stem cells therapies,” said Benito Novas, ISSCA VP of Public Relations. “This year’s event was a great success, and we would like to thank all of the attending physicians, our panel of expert speakers, and the City of Buenos Aires for graciously hosting us.”
To learn more about all of the ISSCA’s latest news and innovations, visit  http://www.stemcellsgroup.com/.

The certification will target physicians in the Middle East and Europe, providing them with critical education to implement stem cells treatments in their own practices
The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, is continuing its mission to become a world leader in regenerative medicine education by adding a new Stem Cells Certification course to its portfolio.
Over the past few months, ISSCA has expanded its reach both through offering new certification courses and by opening new stem cells treatment centers across the globe. The group’s latest Stem Cells Certification course will be offered in Brussels, Belgium, giving physicians in both Europe and the Middle East who have an interest in incorporating regenerative medicine into their practices easier access to critical educational opportunities led by some of the world’s leading experts in the field.
The Brussels course is a collaboration between Belgium-based physician Dr. Samy Joheir, ISSCA Europe, and ISSCA. Participants in the upcoming course are expected to come from the Middle East, specifically from Pakistan and India. The participating physicians are eager to add cell therapies to their practices to better serve patients who are suffering from degenerative conditions.
Physicians attending the certification will learn easy-to-implement protocols that will allow them to harvest and reintegrate stem cells in their own medical offices. The practices shared in the certification will focus on utilization of two different resources: fat tissue and bone marrow tissue.
Physicians interested in learning more about any of ISSCA’s Stem Cells Certification courses are invited to visit https://www.stemcelltraining.net/belgium-hands-on-course/
“The ISSCA is continuing to make good on its mission to alleviate human suffering due to degenerative diseases by providing more physicians across the globe access to critical stem cells training courses,” said Benito Novas, ISSCA VP of Public Relations. “The upcoming course in Belgium will give physicians across Europe and the Middle East critical opportunities to obtain the education needed to utilize today’s cutting-edge stem cells therapies and give them the tools they need to incorporate these life-changing protocols into their own practices.”
To learn more about all of the ISSCA’s latest news and innovations, visit  http://www.stemcellsgroup.com/.